[Fluoxetine: an update of its use in major depressive disorder in adults].

No abstract is available for this paper.

• Publication year

  2004

• Venue

  L'Encephale

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15597466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methodology of measuring the efficacy of antidepressants

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

  2002cited by this paper
• Antidepressants and neuroplasticity.

  2002cited by this paper
• Serotonergic gene expression and depression: implications for developing novel antidepressants.

  2001cited by this paper
• Long-term costs of treatment for depression: impact of drug selection and guideline adherence.

  2001cited by this paper
• Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis.

  2001cited by this paper
• The Economics of Selective Serotonin Reuptake Inhibitors In Depression

  2001cited by this paper
• The cellular neurobiology of depression

  2001cited by this paper
• Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.

  2001cited by this paper
• Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

  2000cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• [Physiopathologic hypotheses of depression].

  2000cited by this paper
• Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.

  2000cited by this paper
• Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials.

  2000cited by this paper
• Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression

  2000cited by this paper
• Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.

  1999cited by this paper
• DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee.

  1999cited by this paper
• A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.

  1999cited by this paper
• Depression in the community: physician and patient perspective.

  1999cited by this paper
• Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.

  1999cited by this paper
• The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.

  1999cited by this paper
• Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.

  1999cited by this paper
• Stress, glucocorticoids and structural plasticity of the hippocampus.

  1998cited by this paper
• The measurement of retardation in depression.

  1998cited by this paper
• How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria.

  1998cited by this paper
• Depression, sleep, and antidepressants.

  1998cited by this paper
• A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.

  1998cited by this paper
• SSRIs versus tricyclic antidepressants in depressed inpatients: A meta‐analysis of efficacy and tolerability

  1998cited by this paper
• Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins.

  1998cited by this paper
• Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

  1998cited by this paper
• Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

  1998cited by this paper
• A molecular and cellular theory of depression.

  1997cited by this paper
• [Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population].

  1996cited by this paper
• Citalopram versus fluoxetine: a double‐blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice

  1996cited by this paper
• A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

  1995cited by this paper
• Comparative safety and tolerability of selective serotonin reuptake inhibitors

  1995cited by this paper
• Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

  1995cited by this paper
• [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].

  1995cited by this paper
• A Meta‐Analysis of Fluoxetine Outcome in the Treatment of Depression

  1994cited by this paper
• Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects

  1994cited by this paper
• Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

  1994cited by this paper
• Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.

  1994cited by this paper
• Double‐blind study of the efficacy and safety of sertraline versus fluoxetine in major depression

  1993cited by this paper
• Analysis of the Hamilton Depression Rating Scale factors from a double‐blind, placebo‐controlled trial of fluoxetine in geriatric major depression

  1993cited by this paper
• Treatments of depression and the functional capacity to work.

  1992cited by this paper
• Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

  1991cited by this paper
• Frequency of suicide on Gotland after systematic postgraduate education of general practitioners

  1989cited by this paper
• Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression

  1987cited by this paper

• A randomized experimental analysis of the attention training technique: Effects on worry and relevant processes in individuals with probable generalized anxiety disorder.

  2021cites this paper
• Brain Imaging Study on the Pathogenesis of Depression & Therapeutic Effect of Selective Serotonin Reuptake Inhibitors

  2020cites this paper
• EVALUATION OF ANTIDEPRESSANT ACTIVITY OF ETHANOLIC EXTRACT OF OCIMUM SANCTUM (TULSI) LEAF IN WISTAR ALBINO RATS AFTER SUB-ACUTE ADMINISTRATION

  2018cites this paper
• Analytical methodologies for the stereoselective determination of fluoxetine: An overview.

  2018cites this paper
• Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.

  2010cites this paper
• Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine.

  2009cites this paper
• A survey of the potential clinical drug interactions between fluoxetine and co-prescribed

  2009cites this paper
• Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.

  2008cites this paper
• Sertraline, a selective serotonin reuptake inhibitor, affects thirst, salt appetite and plasma levels of oxytocin and vasopressin in rats

  2007cites this paper
• Bioequivalence study of two fluoxetine capsule formulations in healthy Middle Eastern volunteers.

  2006cites this paper
• [Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder].

  2005cites this paper